Wegovy and Stomach Cramps: What's Happening and What You Can Do

Stomach cramps are one of the most reported gastrointestinal side effects of semaglutide (Wegovy) and tend to be most noticeable after starting treatment or stepping up to a higher dose.
Slowed gastric emptying is the underlying mechanism: food moves more slowly through the digestive tract, which can cause cramping, bloating, nausea and changes in bowel habit.
Most cramping is mild to moderate, transient and eases within days to a couple of weeks as the body adapts — but severe or persistent abdominal pain always needs medical assessment.
In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a known, infrequent but serious risk with GLP-1 medicines, and that severe stomach pain radiating to the back is a reason to get urgent help.

Stomach cramps on Wegovy are common, particularly in the first few weeks of treatment or after a dose increase. They happen because semaglutide slows how quickly food leaves the stomach and adjusts signals along the gut, and for many people that adjustment is felt as cramping, bloating or discomfort. They do settle for most people — but there are a few situations where cramps are a signal worth acting on quickly. This page covers the likely causes, practical ways to reduce discomfort, and the warning signs that need prompt medical attention. These are prescription-only medicines; what's right for your specific situation is always a conversation for your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding, managing and monitoring stomach cramps with Wegovy

The first few days after your injection: what the cramping usually means

Picture the scene: it's a couple of days after your Wegovy shot, and there's a dull, griping ache sitting somewhere between your stomach and your lower abdomen. You're not sure whether this is expected or something to worry about.

For most people, it is expected. Semaglutide works partly by slowing gastric emptying, the rate at which food moves from the stomach into the small intestine. That slowing is deliberate; it contributes to the fullness that makes eating less feel natural rather than forced. But the gut notices the change. Gas can build up, gut motility shifts, and the result is cramping that feels a bit like trapped wind or a mild stomach upset. The semaglutide overview on this site explains the broader mechanism if you want context beyond the cramping.

The timing tends to follow a pattern. Cramps often peak in the 24–72 hours after an injection, then ease before the next one. After a dose increase they can return, the gut is re-adjusting again. The NHS notes that gastrointestinal side effects like nausea, diarrhoea, constipation and stomach discomfort are among the most common with Wegovy, and that they generally settle with time.

Eating smaller portions, chewing slowly, and avoiding very fatty or heavily processed meals can all reduce the intensity. Staying well hydrated matters too, particularly if cramping comes alongside loose stools. Some people find that taking their injection on a day when their schedule is quieter (rather than before a busy social occasion) helps them manage the first day or two more comfortably.

Why cramps after your Wegovy shot can feel different from ordinary stomach trouble

Ordinary indigestion or a mild stomach bug usually resolves in a day or two and doesn't track neatly with injection day. Stomach cramping with Wegovy tends to follow the weekly rhythm of the pen. That predictability is actually reassuring: if discomfort reliably appears two days post-injection and fades before the next dose, the mechanism is almost certainly the medicine doing what it's designed to do.

The pattern is also different depending on where in the treatment schedule you are. Early on (the first pen or two at 0.25mg) many people notice very little. It's often at the 0.5mg or 1mg step that gut symptoms become more noticeable, and again when moving to the higher maintenance doses. If you're tracking discomfort across injection cycles, this piece on cramps in the hours after your Wegovy injection breaks down that timeline in more detail.

Worth noting for people managing a busy schedule: the pen that arrives with DPD tracking in a plain, unmarked box needs to stay refrigerated. Keeping it stored properly matters, and so does planning your injection day with a light meal beforehand rather than a large one, that single habit reduces cramping meaningfully for a lot of people. Personal targets and timing are always confirmed by your prescriber.

For those finding that discomfort is worse at night, this page on nocturnal cramping on Wegovy covers why lying flat after eating can compound the problem and what positions tend to help.

When stomach cramps on Wegovy are a warning sign, not just a side effect

This is the part of the page worth reading carefully. Most stomach cramps on Wegovy are uncomfortable but benign. A small number are not.

In January 2026 the MHRA published a Drug Safety Update on GLP-1 receptor agonist medicines (semaglutide included) drawing attention to acute pancreatitis as an infrequent but serious risk. The signal to act on is severe, persistent abdominal pain, particularly pain that radiates through to the back, with or without vomiting. That presentation is not typical cramping from slowed gastric emptying, and it needs same-day medical assessment, call 111 or go to A&E if the pain is intense or you feel very unwell. You can report suspected side effects to the MHRA's Yellow Card scheme if you experience something unexpected.

Other symptoms that move stomach cramps into the 'get assessed' category include: severe pain accompanied by fever, cramps alongside signs of serious dehydration (no urination for many hours, dizziness when standing), pain that is getting progressively worse over hours rather than settling, and any yellowing of the skin or eyes, which can indicate a gallbladder problem. Gallbladder issues (including gallstones) are a recognised side effect of rapid weight loss and are listed in the Wegovy prescribing information.

If you're unsure, err on the side of contacting your GP or prescriber. That instinct is correct, not overcautious. Dose management and how to handle side effects that feel significant are always questions for your clinical team, not something to work through alone. You can also reach the nume aftercare team seven days a week if you're a patient and need guidance.

Practical steps that genuinely help, and what the evidence says about persistence

There is no single fix for stomach cramps on Wegovy, but the combination of adjustments that consistently appears in clinical guidance includes: smaller, lower-fat meals spread across the day rather than two or three large ones; avoiding eating within two to three hours of going to bed; cutting back on carbonated drinks, which add to bloating; and keeping alcohol minimal, since it compounds nausea. Fibre intake matters, both too little and too much can worsen cramping, so a steady moderate intake is the aim.

The NHS medicines page for semaglutide lists dietary adjustments alongside the side-effect information as standard patient guidance.

Persistence is real for some people. If cramping is still significantly affecting daily life after four to six weeks at a given dose (not just the 48 hours post-injection) that's worth raising with your prescriber. In some cases the titration schedule can be extended: staying at the current dose for longer before stepping up. That decision belongs with the clinician. An overview of the broader side-effect profile and how it fits into the treatment picture is on the Wegovy information page.

If you're curious about how the cost of treatment fits into the picture, the Wegovy cost page covers what private treatment typically includes. And if fatigue is running alongside your cramps, the page on lethargy and tiredness on Wegovy addresses that combination, which is more common than people expect in the early weeks.

When cramps are under control and you feel ready to explore whether Wegovy is right for you, a free consultation with our prescribers is the next step. A real clinician reviews your responses the same day and discusses suitability with you, no automated decisions.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions